Optimal Injection Interval for Intra-Detrusor Botulinum Toxin

NCT06483217 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder
Urinary Urgency
Urinary Incontinence
Urge Urinary Incontinence

Interventions

BEHAVIORAL: Patient-directed follow up

Sponsor

Louisiana State University Health Sciences Center in New Orleans